WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker in advance of House consideration tomorrow of the American Health Care Act:
Press Release | March 22, 2017
Press Release | March 21, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that CVRx President and CEO Nadim Yared has been named chairman of the AdvaMed Board of Directors for a two-year term.
Press Release | March 21, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed), issued the following statement from President and CEO Scott Whitaker on today’s hearing in the Senate Health, Education, Labor, and Pensions Committee on reauthorization of the Medical Device User Fee Act:
March 29, 2017 to March 30, 2017| Washington, DC
During this workshop you'll establish a clear understanding how the regulatory affairs function is pivotal to every recall and every team decision. After partaking in ... Read More
April 11, 2017 to April 12, 2017| Washington, DC
Whether you’re a large device company or an emerging medtech organization, one thing is true: the industry is changing and evolving, creating an ever-changing landscape, bringing with it, new... Read More
Medical technology aids in the prevention, diagnosis and treatment of various conditions to enhance quality of life and help you enjoy more of life's precious moments.
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.
Creating life-changing innovations is central to the role the medical technology industry plays in improving patient care. For people with neurological conditions — like spina bifida, epilepsy, Parkinson’s, multiple sclerosis and many others — advances in medical technology are not only improving, but also saving lives. Unbeknownst to many, however, is how one harmful tax policy is creating unnecessary barriers to future advances, and negatively affecting those living with chronic diseases and...
AdvaMed CEO Scott Whitaker on the impact of Obamacare and its medical device tax.
Wisconsin State Journal
The United States has long been a leader in medical technology innovation and discovery, and Wisconsin has been a leading state in medical breakthroughs and medical device manufacturing. Unfortunately, we have tax policies, including the medical device tax, that have stifled innovation and job creation, putting our research and technological leadership at risk.
The Journal Gazette
From artificial joints to replacement heart valves, hospital beds to radiation therapies, the economic and human impact of medical technology innovation cannot be overstated. Medical technology companies that innovate quickly and at high levels of quality create and sustain well-paying jobs and, most importantly, save and improve the lives of patients. And that is why permanent repeal of the medical device tax must be a priority for the 115th Congress in 2017. The 2.3 percent excise tax on...
March 22, 2017 - 5:58pm